David Westerman

6.6k citations
161 papers · 5.2k · 2 hit papers · h-index 34

Impact in

  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation

Papers in

    • Chronic Lymphocytic Leukemia Research 48
    • Acute Myeloid Leukemia Research 23
    • Multiple Myeloma Research and Treatments 12
    • Hematopoietic Stem Cell Transplantation 5

David Westerman

148 papers receiving 5.1k citations

David Westerman's Hit Papers

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia 2018 · 346 citations
3460+2+5Years since publication100200300

Peers

David Westerman
Comparison fields: 5 of 94
  • Genetics 1.6k
  • Hematology 904
  • Pathology and Forensic Medicine 849
  • Biochemistry 285
  • Dermatology 218
Replace Muhıt Özcan with:
Muhıt Özcan Türkiye
Alberto Álvarez‐Larrán Spain
Jon D. van der Walt United Kingdom
Michael Steurer Austria
Carlos Panizo Spain
Kazuo Muroi Japan
Jae Hoon Lee South Korea
Andreas Hüttmann Germany
Caterina Cecilia Stelitano Italy
Judit Demeter Hungary
David Westerman relative to Muhıt Özcan Türkiye Muhıt Özcan's profile →
Citations per field
00.5×2×4×6×8×9.2×
Muhıt Özcan · 1×
Citations per year

Countries citing papers authored by David Westerman

Since Specialization
Citations

This map shows the geographic impact of David Westerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Westerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Westerman more than expected).

Fields of papers citing papers by David Westerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Westerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Westerman. The network helps show where David Westerman may publish in the future.

Co-authors

The 25 scholars most cited alongside David Westerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Westerman Line = papers co-authored together David Westerman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2013391
2 2013365
3
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
Hit paper breakdown →
2018346
4
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Hit paper breakdown →
2018337
5 2016256
6 2014191
7 2015190
8 2016173
9 2017153
10 2017143
11 2020134
12 2016125
13 2014113
14 201089
15 201784
16 200679
17 202074
18 202164
19
Treatment-related myelodysplasia following fludarabine combination chemotherapy.
200663
20 201861

About David Westerman

David Westerman is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Dermatology and Oncology, having authored 161 papers that have together received 5.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (48 papers), Lymphoma Diagnosis and Treatment (30 papers), Acute Myeloid Leukemia Research (23 papers), Multiple Myeloma Research and Treatments (12 papers), Acute Lymphoblastic Leukemia research (11 papers), Cutaneous lymphoproliferative disorders research (6 papers), CAR-T cell therapy research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Genetics (1.6k citations), Hematology (904 citations), Pathology and Forensic Medicine (849 citations), Biochemistry (285 citations) and Dermatology (218 citations). David Westerman has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include John Francis Seymour, Constantine Si Lun Tam, Henry Miles Prince, Piers A. Blombery, Andrew Warwick Roberts, Mary Ann Anderson, Stephen Lade, David C.S. Huang, Ella R. Thompson and Elchanan H. Januszewicz. Their work appears in journals such as Blood, British Journal of Haematology, Haematologica, Pathology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact